Announcements Trials
Browse Landscape

Status

Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Interventional 56Observational 11Expanded_access 1

Sponsor

Cancer Type

Sarcoma 4Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma 13Recurrence 10Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Non-Hodgkin 7Leukemia, Myeloid, Acute 7Leukemia, Lymphocytic, Chronic, B-Cell 6Lymphoma, Mantle-Cell 5Leukemia 5Hodgkin Disease 5Neoplasms 4Myelodysplastic Syndromes 4Multiple Myeloma 4Waldenstrom Macroglobulinemia 3Lymphoma, Follicular 3Hematologic Diseases 3Sarcoma 2Primary Myelofibrosis 2Precancerous Conditions 2Mastocytosis, Systemic 2Lymphoproliferative Disorders 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell 2Leukemia, Mast-Cell 2Immunoproliferative Disorders 2Immunologic Deficiency Syndromes 2Immune System Diseases 2

Interventions

glucarpidase 1Carboxypeptidases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Osteosarcoma × Lymphoid × Clear all
NCT00481559 2014-01-17

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

BTG International Inc.

Approved for marketing
LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neoplasms, Osteosarcoma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡